Oncotarget’s rising popularity as an online research platform is directly attributed to its constructive and insightful ability to accept high-quality research material from various scholars. With its free access policy, readers are provided with unlimited access to first-hand articles on various fields ranging from pharmacology, neuroscience, cardiology and endocrinology. In essence, oncotarget is a dynamic term that incorporates cellular functions, pathways, neurodegeneration, molecules and neurons. To expedite reading purposes, articles derived from the platform can be viewed online or printed on special demand.Under the insightful leadership of Oncotarget, Oncotarget’s presence in the academic field remains paramount. It adheres to impressive missions such as maximizing research via insightful learning tools. More importantly, such exceptional discoveries facilitate quick transfer of knowledge among readers. The Editorial Board also deemed it necessary to eliminate borders hindering the absorption of knowledge among researchers.
Oncotarget’s Board of Editors
Oncotarget’s highly effective board of directors is credited with the unprecedented success witnessed over the years. Such a team essentially includes editors-in-chief such as Andrei V. Gudkov and Mikhail Blagosklonny both from the Roswell Park Cancer Institute, Buffalo, NY. Additionally, the Founding Editorial Board consists of Cory Abate-Shen, Dario Altieri, Stephen Baylin, Bruce Blazar, Kenneth Cowan and much more.
Sections Studied Under Oncotarget
Also known as Aging, this field focuses on all areas of aging including signal transduction pathways, cellular senescence and metabolic syndrome. Additionally, the section also focuses on Parkinson’s disease and hypertension.
Under the pathology section, Michael Lisanti has gone above and beyond to develop pathology into a high-quality research section. Since Oncotarget’s formation in 2010, the section’s rapid growth has successfully led to the issuance of several advantages such as ultra-rapid publication and higher impact factor.
How It Works
Submitting an article essentially acts as the first step before any document can be accepted for review. This means that authors must understand and accept outlined policies and have complied with the instructions to the letter. Afterward, the article is submitted on the submission page for consideration and review within the shortest time possible.
Conflict Of Interest
The platform’s policy mandates reviewers and authors to reveal to the senior editors, scientific editors and deputy editors any relationship that could lead to the potential and actual conflict of interest regarding the article submitted for review.